14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CNBX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Cannabics Pharma stock upgraded to Hold/Accumulate.
(Updated on Apr 23, 2024)

Hold candidate since Apr 23, 2024 PDF

The Cannabics Pharma stock price gained 3.13% on the last trading day (Tuesday, 23rd Apr 2024), rising from $0.0120 to $0.0124. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.67% from a day low at $0.0120 to a day high of $0.0127. The price has risen in 6 of the last 10 days and is up by 9.29% over the past 2 weeks. Volume fell on the last day by -53 thousand shares and in total, 20 thousand shares were bought and sold for approximately $249.67 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.00% during the next 3 months and, with a 90% probability hold a price between $0.0106 and $0.0186 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CNBX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 18.75%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cannabics Pharma stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0136. On a fall, the stock will find some support from the short-term average at $0.0118. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cannabics Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0112 and $0.0110. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cannabics Pharma finds support just below today's level at $0.0112. If this is broken, then the next support from accumulated volume will be at $0.0110 and $0.0106.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0007 between high and low, or 5.67%. For the last week the stock has had daily average volatility of 18.81%.

Our recommended stop-loss: $0.0119 (-3.60%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (CNBX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Cannabics Pharma to open at $0.0123, and during the day (based on 14 day Average True Range), to move between $0.0096 and $0.0151, which gives a possible trading interval of +/-$0.0028 (+/-22.35%) up or down from last closing price. If Cannabics Pharma takes out the full calculated possible swing range there will be an estimated 44.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0125 (1.21%) than the support at $0.0112 (9.72%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cannabics Pharma stock A Buy?

Cannabics Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.247 Hold/Accumulate Upgraded

Predicted Opening Price for Cannabics Pharma of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$0.0123 ( 0.0540%) $0.0124

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CNBX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0130 5.45 %
R2 0.0128 3.35 %
R1 0.0126 2.05 %
Current price: 0.0124
Support S1 0.0121 -2.16 %
S2 0.0119 -3.46 %
S3 0.0117 -5.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0150 21.13 %
R2 0.0132 6.88 %
R1 0.0125 1.21 %
Current price 0.0124
Support S1 0.0112 -9.72%
S2 0.0110 -10.93%
S3 0.0106 -14.17%

FAQ

What is the symbol for Cannabics Pharma Stock and on which exchange is it traded?
The symbol for Cannabics Pharma is CNBX and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Cannabics Pharma Stock?
Cannabics Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Cannabics Pharma Stock?
Cannabics Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cannabics Pharma Stock.

What's the current price of Cannabics Pharma Stock?
As of the end of day on the Apr 23, 2024, the price of an Cannabics Pharma (CNBX) share was $0.0124.

What is the 52-week high and low for Cannabics Pharma Stock?
The 52-week high for Cannabics Pharma Stock is $0.0487 and the 52-week low is $0.0085.

What is the market capitalization of Cannabics Pharma Stock?
As of the Apr 23, 2024, the market capitalization of Cannabics Pharma is 372.559K.

When is the next earnings date for Cannabics Pharma?
The upcoming earnings date for Cannabics Pharma is Jul 14, 2024.
Click to get the best stock tips daily for free!

About Cannabics Pharma

Cannabics Pharma CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal p... CNBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT